alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2018460EN.01002801.xml

| 21.12.2018 | EN | Official Journal of the European Union | C 460/28 |
| --- | --- | --- | --- |

21.12.2018

EN

Official Journal of the European Union

C 460/28

---

Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)

(Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (1)
  )

(Text with EEA relevance)

(2018/C 460/13)

Decisions granting an authorisation

| Reference of the decision (2) | Date of decision | Substance name | Holder of the authorisation | Authorisation number | Authorised use | Date of expiry of review period | Reasons for the decision |
| --- | --- | --- | --- | --- | --- | --- | --- |
| C(2018) 8490 | 14 December 2018 | 1,2-dichloroethane
  EC No 203-458-1
  CAS No 107-06-2 | emp Biotech GmbH, Robert-Roessle-Str. 10, 13125, Berlin, Germany | REACH/18/20/0 | Use of 1,2-dichloroethane as a solvent in manufacture of polymeric particles for pharmaceutical and research purification processes | 22 November 2029 | In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socio-economic benefits outweigh the risk to human health and the environment arising from the use of the substance and there are no suitable alternative substances or technologies for the applicant before the sunset date. |

Reference of the decision (2)

Date of decision

Substance name

Holder of the authorisation

Authorisation number

Authorised use

Date of expiry of review period

Reasons for the decision

C(2018) 8490

14 December 2018

1,2-dichloroethane

EC No 203-458-1

CAS No 107-06-2

emp Biotech GmbH, Robert-Roessle-Str. 10, 13125, Berlin, Germany

REACH/18/20/0

Use of 1,2-dichloroethane as a solvent in manufacture of polymeric particles for pharmaceutical and research purification processes

22 November 2029

In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socio-economic benefits outweigh the risk to human health and the environment arising from the use of the substance and there are no suitable alternative substances or technologies for the applicant before the sunset date.

---

(1)  OJ L 396, 30.12.2006, p. 1.

(2)  The decision is available on the European Commission website at: http://ec.europa.eu/growth/sectors/chemicals/reach/about/index_en.htm

---
No. 12-5944.

#### Cesal *v.*Cross, Warden.

C. A. 7th Cir. Cer-tiorari denied.

Justice Kagan took no part in the consideration or decision of this petition.
<PAGE>


EXHIBIT 99.2

                                  CERTIFICATION

     Pursuant  to  Section  906 of the  Public  Company  Accounting  Reform  and
Investor  Protection  Act of 2002 (18  U.S.C.ss.  1350,  as  adopted),  David W.
Brunton,  the Chief  Financial  Officer  of SBE,  Inc.  (the  "Company")  hereby
certifies that, to the best of his knowledge:

     1. The Company's  Annual Report on Form 10-K for the year ended October 31,
     2002,  to which  this  Certification  is  attached  as  Exhibit  99.2  (the
     "Periodic  Report"),  fully complies with the requirements of Section 13(a)
     or Section 15(d) of the Securities Exchange Act of 1934, as amended; and

     2. The information contained in the Periodic Report fairly presents, in all
     material respects, the financial condition of the Company at the end of the
     period  covered by the  Periodic  Report and results of  operations  of the
     Company for the period covered by the Periodic Report.

Dated:   January 24, 2003

/s/ David W. Brunton
----------------------------
David W. Brunton
Chief Financial Officer




<PAGE>
EXHIBIT 32.1



AMERICAN BUSINESS CORPORATION



CERTIFICATION PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002



In
connection with the Quarterly Report of American Business Corporation on Form 10-QSB for the quarterly period ended June 30, 2005, as filed with the Securities and Exchange Commission on August 12, 2005 (the Report), the undersigned, in
the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2003, that:



(1) The Report fully complies with requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2) The information contained in the Report fairly presents,
in all material respects, the financial condition and results of operations of American Business Corporation.



Date: August 12, 2005



|                           
|---------------------------
|/s/ Anthony R. Russo       
|Chief Executive Officer    
|and Chief Financial Officer
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                         581,653
<SECURITIES>                                         0
<RECEIVABLES>                                3,297,391
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             3,917,823
<PP&E>                                         100,651
<DEPRECIATION>                                  70,292
<TOTAL-ASSETS>                               4,364,644
<CURRENT-LIABILITIES>                        1,112,951
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         6,895
<OTHER-SE>                                   3,367,233
<TOTAL-LIABILITY-AND-EQUITY>                 4,364,644
<SALES>                                      3,050,876
<TOTAL-REVENUES>                             3,052,407
<CGS>                                        2,207,314
<TOTAL-COSTS>                                2,598,456
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              10,738
<INCOME-PRETAX>                                453,951
<INCOME-TAX>                                   185,854
<INCOME-CONTINUING>                            268,097
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   268,071
<EPS-PRIMARY>                                     0.04
<EPS-DILUTED>                                        0
        

</TABLE>
Exhibit 99.2



                    CERTIFICATION PURSUANT TO
                     18 U.S.C. SECTION 1350,
                      AS ADOPTED PURSUANT TO
          SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



     In connection with the Quarterly Report of Micronetics, Inc.
(the "Company") on Form 10-QSB/A for the period ending June 30, 2002,
as filed with the Securities and Exchange Commission on the date
hereof (the "Report"), Dennis Dow, Financial Consultant of the Company
certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section  906 of the Sarbanes-Oxley Act of 2002, that, to the best of
his knowledge:

          (1)  The Report fully complies with the requirements of
Section 13(a) or Section 15(d) of the Securities Exchange Act of
1934; and

          (2)  The information contained in the Report fairly
presents, in all material respects, the financial condition and
result of operations of the Company.



February 18, 2003              /s/Dennis Dow
                               ----------------------------------
                               Name: Dennis Dow
                               Title: Vice President-Finance
                                      (Principal Financial Officer)





     This certification accompanies the Report pursuant to Section
906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the
extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by
the Company for purposes of Section 18 of the Securities Exchange Act
of 1934, as amended.
#### State v. Harris

112,120

07/07/2016

Denied.

Unpubhshed
Offer Letter of Employment from Paradise Electronics to Mohammad Tafazzoli



 Exhibit 10.7 
  
 [LOGO OF PARADISE ELECTRONICS] 

 Mohammad Tafazzoli 
 8659 Briarwood Lane 
 Dublin, CA 94568 
  
 February 17, 1998 
  
 Dead Mohammad, 

 
 We would like to take this opportunity to extend to you a formal offer of employment on
behalf of Paradise Electronics, Inc. (the “Company”). The following terms reflect our offer. 
  
 1)    Position: You will server as a Product and Test Engineering Manager for the Company. 
  
 2)    Salary and Fringe Benefits: Your salary will be set at the annualized rate of $101,000, and will be payable in accordance with standard Company
practice with respect to employee compensation. You will be enrolled in all of the Company’s benefit plans with the same privileges as other Company employees of the same class. Your vacation accrual will also be commensurate with that of the
above group of Company employees. 
  
 3)    The Company will
grant to you, subsequent to the commencement of your employment and subject to approval by the Company’s Board of Directors, the right to purchase 60,000 shares of Company’s Common Stock at a price which will be determined during the next
board meeting. These options will vest over 4 years with 25% of the options vesting after the first full year of your employment and the remaining 75% of the shares vesting in equal monthly increments over the remaining 3 years of your employment.

  
 4)    Proprietary Information and Inventions Agreement:
As a condition of your employment, you will be required to sign the Company’s Standard Proprietary Information and Inventions Agreement. 
  
 5)    In addition to your annual salary you will be paid a one time $10,000 performance bonus on September 15, 1998 based on your completion of a
mutually agreed upon set of goals that will be set during your first month of employment. 
  
 This letter supersedes all prior written or oral communications or agreements, express or implied, regarding your employment by the Company. This letter is not an employment contract; instead, it reflects the
compensation level during your employment at the Company. As you know, the Company cannot and does not make any promises regarding the duration of the employment period for any employee, who can terminate voluntarily or be terminated involuntarily
with or without cause at any time. Please acknowledge receipt of this letter and acceptance of its content by signing it and returning it to me. 
  
  

	Sincerely,	 	 
		
	 /s/    WENDY BENVENISTE

	 	  
	 Wendy Benveniste
 Vice President
Operations
	 	 
		
	Accepted and Agreed to by:	 	 
		
	 /s/    MOHAMMAD TAFAZZOLI

	 	 02/25/98


	Mohammad Tafazzoli	 	Date
Exhibit 32.1


CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Quarterly Report of International Automated Systems, Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Neldon Johnson, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:





(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.





/s/ Neldon Johnson


Neldon Johnson


President, Chief Executive Officer


May 13, 2011




---
# C_2018413EN.01001204.xml

| 14.11.2018 | EN | Official Journal of the European Union | C 413/12 |
| --- | --- | --- | --- |

14.11.2018

EN

Official Journal of the European Union

C 413/12

---

SHIFT2RAIL JOINT UNDERTAKING

Publication of the final accounts for the financial year 2017

(2018/C 413/47)

The complete version of the final accounts may be found at the following address:

https://shift2rail.org/about-shift2rail/reference-documents/

---
Exhibit 32.2

CERTIFICATION PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

I, Dawn H. Bertsche, Senior Vice President Finance and Chief Financial Officer of Multi-Color Corporation (the Company), certify pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:



|(1) | the Quarterly Report on Form 10-Q of the Company for the period ended June 30, 2006 (the Report) fully complies with the requirements of Section 13(a) or 15(d)
of the Securities Exchange Act of 1934; and
|--- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|(2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|--- | ----------------------------------------------------------------------------------------------------------------------------------------------------

Date: August 4, 2006



By:

/s/ Dawn H. BertscheDawn H. BertscheSenior Vice President Finance,Chief Financial Officer and Secretary
|/Documents%20and%20Settings/LPJ/EMEU/styles/eia_sitewideF.css" rel="stylesheet" type="text/css" />

|**Arizona:** The numbers on the state map shown here represent the NOAA climate divisions. The previous version
of the CBECS climate zone map incorrectly placed climate divisions 3, 4, and 7 into CBECS climate zone 3 (yellow). 
These three climate divisions are in CBECS climate zone 4 (orange), as shown on the corrected version of the map.
      Arizona map                                                                                                                                                        
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|**South Carolina:** The numbers on the state map shown here represent the NOAA climate divisions. The previous 
        version of the CBECS climate zone map incorrectly placed climate division 1 into CBECS climate zone 4 (orange). This climate division is in CBECSclimate zone 3 (yellow), as shown on the corrected version of the map.
    South Carolina Map
        Return to Climate Zone MapContacts:Specific questions on this product may be directed to:Joelle MichaelsJoelle.Michaels@eia.doe.govCBECS Manager
No. 110,452

#### In the Matter of Kevin E. Dellett, *Respondent.*

Effective this 31st day of May, 2016.

(377 P.3d 413)

On March 28, 2014, this court placed the respondent, Kevin E. Dellett, on probation for a period of 2 years with specific conditions. *In re Dellett,*299 Kan. 69, 324 P.3d 1033 (2014).

The Disciplinary Administrator filed a report verifying that the respondent has fully complied with all conditions imposed on him by this court and recommending that the respondent be discharged from probation.

This court, having reviewed the files and the recommendation of the office of the Disciplinary Administrator, finds that the respondent should be discharged from probation.

It Is Therefore Ordered that the respondent is hereby discharged from probation and from any further obligation in this matter and that this proceeding is closed.

It Is Further Ordered that this order be published in the Kansas Reports and that the costs herein be assessed to the respondent.
No. 12-5527.

#### Meirick *v.*United States.

C. A. 8th Cir. Certiorari denied.
[Federal Register Volume 62, Number 51 (Monday, March 17, 1997)]
[Notices]
[Page 12641]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-6646]


-----------------------------------------------------------------------

FEDERAL COMMUNICATIONS COMMISSION
[Report No. 2179]


Petitions for Reconsideration of Action in Rulemaking Proceeding

March 12, 1997.
    Petitions for reconsideration have been filed in the Commission's 
rulemaking proceeding listed in this Public Notice and published 
pursuant to 47 CFR Section 1.429(e). The full text of these documents 
are available for viewing and copying in Room 239, 1919 M Street NW., 
Washington, DC or may be purchased from the Commission's copy 
contractor, ITS, Inc. (202) 857-3800. Oppositions to these petitions 
must be filed April 1, 1997. See Section 1.4(b) (1) of the Commission's 
rules (47 CFR 1.4(b)(1)). Replies to an opposition must be filed within 
10 days after the time for filing oppositions has expired.

Subject: Amendment of The Commission's Rules to Provide for Operation 
of Unlicensed NII Devices in the 5 GHz Frequency Range.
Number of Petitions Filed: 3.

Federal Communications Commission.
William F. Caton,
Acting Secretary.
[FR Doc. 97-6646 Filed 3-14-97; 8:45 am]
BILLING CODE 6712-01-M
Fourth Court of Appeals

San Antonio, Texas

February 21, 2020

No. 04-19-00799-CV

IN THE INTEREST OF B.R.W., A CHILD

From the 45th Judicial District Court, Bexar County, Texas

Trial Court No. 2016-CI-11037

Honorable Mary Lou Alvarez, Judge Presiding

ORDER

Appellant, representing himself, filed a brief on February 10, 2020. Appellant’s brief

recites alleged facts pertaining to his complaints about his child support enforcement case. 

Appellant’s brief does not comply with Rule 38.1 of the Texas Rules of Appellate 

Procedure. See TEX. R. APP. P. 38.1. Specifically, the brief does not include the following:

• Table of Contents (that complies with the Rules),

• Index of Authorities,

• Statement of Facts (that complies with the Rules),

• Summary of the Argument,

• Argument, 

• an Appendix (that complies with the Rules), or

• Certificate of Compliance.

See id. R. 9.4, 9.5, 38.1. The brief has these additional defects.

• No part of the brief contains any citations to the record. Contra id. R. 38.1(g) (“The 

statement [of facts] must be supported by record references.”); id. R. 38.1(i) (“The 

brief must contain . . . appropriate citations . . . to the record.”). 

• The portions of the brief that may be construed as a statement of facts recite alleged 

facts and complaints, but the brief does not state how the trial court erred or present 

any legal arguments, with appropriate citations to authorities and the record, to 

present any legal basis for this court to reverse the trial court’s judgment. Contra

TEX. R. APP. P. 38.1(i). 

• The brief does not recite the standard of review and it contains no citations to statutes, 

rules, or case law. Contra id. (requiring “appropriate citations to authorities”). 

In its current form, Appellant’s brief does not present anything for appellate review. 
This court may order a party to amend, supplement, or redraw a brief if it flagrantly 

violates Rule 38. See id. R. 38.9(a). We conclude that the defects described above constitute 

flagrant violations of Rule 38. 

Therefore, we STRIKE Appellant’s brief and ORDER Appellant to file an amended brief 

within TEN DAYS of the date of this order. The amended brief must correct all the 

violations listed above and fully comply with the applicable rules. See, e.g., id. R. 9.4, 9.5, 

38.1. If the amended brief does not comply with this order, we “may strike the brief, prohibit 

[Appellant] from filing another, and proceed as if [Appellant] had failed to file a brief.” See id.

R. 38.9(a); see also id. R. 38.8(a) (authorizing this court to dismiss an appeal if an appellant fails 

to timely file a brief). 

If Appellant timely files a brief that complies with this order, Appellees’ brief will be due 

thirty days after Appellant’s brief is filed. See TEX. R. APP. P. 38.6(b). 

_________________________________

Patricia O. Alvarez, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said 

court on this 21st day of February, 2020.

___________________________________

Michael A. Cruz,

Clerk of Court
III 

111TH CONGRESS 

1ST SESSION S. RES. 324 

Designating November 1, 2009, as ‘‘National Hemangioma Treatment 

Awareness Day’’. 

IN THE SENATE OF THE UNITED STATES 

OCTOBER 27, 2009 

Mr. GRAHAM submitted the following resolution; which was considered and 

agreed to 

RESOLUTION 

Designating November 1, 2009, as ‘‘National Hemangioma 

Treatment Awareness Day’’. 

Whereas hemangiomas are the most common benign tumors 

that occur in infancy; 

Whereas hemangiomas appear at birth, or within the first 

several months of life; 

Whereas, each year, approximately 400,000 children in the 

United States are born with hemangiomas and other vascular anomalies; 

Whereas hemangiomas and other vascular anomalies can have 

a negative effect on the emotional development of a child; 

Whereas awareness of the impact of hemangiomas and vascular anomalies on children, their families, and society 


srobinson on DSKHWCL6B1PROD with BILLS
2 

•SRES 324 ATS 

will lead to improvements in the care of children with 

hemangiomas; 

Whereas the National Institutes of Health supports research 

on the treatment of, and cure for, hemangiomas and 

other vascular anomalies; 

Whereas The Hemangioma Treatment Foundation has the 

unique mission of providing treatment to children affected with hemangiomas and other vascular anomalies; 

and 

Whereas The Hemangioma Treatment Foundation is dedicated to finding a cure for hemangiomas and other vascular anomalies: Now, therefore, be it 

1 Resolved, That the Senate— 

2 (1) designates November 1, 2009, as ‘‘National 

3 Hemangioma Treatment Awareness Day’’; and 

4 (2) respectfully requests that the Secretary of 

5 Senate transmit a copy of this resolution to The 

6 Hemangioma Treatment Foundation. 

Æ 


srobinson on DSKHWCL6B1PROD with BILLS
UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 205492

											

Form 10-Q

[X]    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES

          EXCHANGE ACT OF 1934

          For the quarterly period ended September 30, 2003

OR

[  ]     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES

          EXCHANGE ACT OF 1934

          For the transition period from                           to                                       
Commission File Number 000-21267

SUMMIT BANK CORPORATION
#### State v. LaPointe

112,019

02/18/2016

Granted.

51 Kan. App. 2d 742